What is the optimal b value in diffusion-weighted MR imaging to depict prostate cancer at 3T?
- First Online:
To determine an optimal b value to visualise prostate cancer using diffusion-weighted magnetic resonance imaging at 3 T.
Forty one patients with biopsy proven prostate cancer underwent 3 T diffusion-weighted MRI performed with 5 b values (0, 1,000, 1,500, 2,000, 2,500 s/mm2) using a 16-channel coil. Best lesion visibility, the central gland-lesion (CG-L) and the peripheral zone-lesion (PZ-L) contrast-to-noise ratio (CNR) were compared between different b value images, apparent diffusion coefficient (ADC) were measured. In a subset of 29 patients a high resolution b1,500 s/mm2diffusion-weighted sequence was additionally assessed.
The b = 1,500 s/mm2 and b = 2,000 s/mm2 images provided the best lesion visibility respectively in 27/41 and in 10/41patients. The highest CG-L and PZ-L CNR were obtained with b = 1,500 s/mm2 (P < 0.0001). The mean ADC value calculated from 0 to 1,500 s/mm2 b values in cancer lesions (ADC = 736 ± 173 10−6 mm2/s) was statistically significantly lower than in the peripheral zone (ADC = 1,338 ± 256 10−6 mm2/s, P < 0.0001) and in the central gland (ADC = 1,270 ± 239 10−6 mm2/s, P < 0.0001). The high resolution diffusion sequence was judged of better lesion visibility than (17/29) or equivalent to (6/29) the best images from the 5b sequence.
At 3 T, prostate cancer lesions are best depicted with b = 1,500 s/mm2 and b = 2,000 s/mm2 images, b = 1,500 s/mm2 high-resolution diffusion images improve the image quality and contrast.
• Multiple b ≥ 1,000 s/mm23 T-DW Magnetic Resonance Imaging provides excellent prostate cancer depiction.
• Prostate DWI and ADC maps are attainable at 3 T without endorectal coil.
• Prostate cancer depiction is improved on high resolution b 1,500 s/mm23 T-DWI.
KeywordsProstate cancer Magnetic resonance imaging Diffusion High b value High field MRI
- 7.Turkbey B, Shah VP, Pang Y, Bernardo M, Xu S, Kruecker J, Locklin J, Baccala AA Jr, Rastinehad AR, Merino MJ, Shih JH, Wood BJ, Pinto PA, Choyke PL (2011) Is apparent diffusion coefficient associated with clinical risk scores for prostate cancers that are visible on 3-T MR images? Radiology 258:488–495PubMedCrossRefGoogle Scholar
- 8.Hambrock T, Somford DM, Huisman HJ, van Oort IM, Witjes JA, Hulsbergen-vande Kaa CA, Scheenen T, Barentsz JO (2011) Relationship between apparent diffusion coefficients at 3.0-T MR imaging and Gleason grade in peripheral zone prostate cancer. Radiology 259:453–461Google Scholar
- 12.Katahira K, Takahara T, Kwee TC, Oda S, Suzuki Y, Morishita S, Kitani K, Hamada Y, Kitaoka M, Yamashita Y (2011) Ultra-high-b-value diffusion-weighted MR imaging for the detection of prostate cancer: evaluation in 201 cases with histopathological correlation. Eur Radiol 21:188–196PubMedCrossRefGoogle Scholar
- 13.Willinek WA, Gieseke J, Kukuk GM, Nelles M, König R, Morakkabati-Spitz N, Träber F, Thomas D, Kuhl CK, Schild HH (2010) Dual-source parallel radiofrequency excitation body MR imaging compared with standard MR imaging at 3.0 T: initial clinical experience. Radiology 256:966–975PubMedCrossRefGoogle Scholar
- 16.Heijmink SW, Fütterer JJ, Hambrock T, Takahashi S, Scheenen TW, Huisman HJ, Hulsbergen-Van de Kaa CA, Knipscheer BC, Kiemeney LA, Witjes JA, Barentsz JO (2007) Prostate cancer: body-array versus endorectal coil MR imaging at 3 T–comparison of image quality, localization, and staging performance. Radiology 244:184–195PubMedCrossRefGoogle Scholar
- 21.Reeder SB, Wintersperger BJ, Dietrich O, Lanz T, Greiser A, Reiser MF, Glazer GM, Schoenberg SO (2005) Practical approaches to the evaluation of signal-to-noise ratio performance with parallel imaging: application with cardiac imaging and a 32-channel cardiac coil. Magn Reson Med 54:748–754PubMedCrossRefGoogle Scholar